The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
896963522 8969635 22 F 20121210 20160916 20121218 20160926 EXP PHHY2012CA116204 NOVARTIS 65.92 YR F Y 0.00000 20160926 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
896963522 8969635 1 PS TASIGNA NILOTINIB 1 Oral 300 MG, BID 22068 300 MG CAPSULE BID
896963522 8969635 2 C BENEFIBER STARCH, WHEAT 1 Unknown U 0
896963522 8969635 3 C INSULIN INSULIN NOS 1 Unknown U 0
896963522 8969635 4 C FLAXSEED FLAX SEED 1 Unknown U 0
896963522 8969635 5 C MILK OF MAGNESIA MAGNESIUM HYDROXIDE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
896963522 8969635 1 Chronic myeloid leukaemia
896963522 8969635 2 Constipation
896963522 8969635 3 Blood pressure measurement
896963522 8969635 4 Constipation
896963522 8969635 5 Constipation

Outcome of event

Event ID CASEID OUTC COD
896963522 8969635 HO
896963522 8969635 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
896963522 8969635 Alopecia
896963522 8969635 Anxiety
896963522 8969635 Asthenia
896963522 8969635 Blood glucose increased
896963522 8969635 Blood sodium decreased
896963522 8969635 Blood urine present
896963522 8969635 Concomitant disease aggravated
896963522 8969635 Constipation
896963522 8969635 Decubitus ulcer
896963522 8969635 Dry mouth
896963522 8969635 Dysphagia
896963522 8969635 Fall
896963522 8969635 Fatigue
896963522 8969635 Flatulence
896963522 8969635 Hypertension
896963522 8969635 Infection
896963522 8969635 Internal haemorrhage
896963522 8969635 Intestinal obstruction
896963522 8969635 Malaise
896963522 8969635 Nasopharyngitis
896963522 8969635 Nausea
896963522 8969635 Peripheral swelling
896963522 8969635 Rhinorrhoea
896963522 8969635 Skin disorder
896963522 8969635 Somnolence
896963522 8969635 Staphylococcal infection
896963522 8969635 Sunburn
896963522 8969635 Urinary tract infection
896963522 8969635 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
896963522 8969635 1 20121210 0